OncoDNA

OncoDNA is a theranostic and genomic company focused on precision medicine in oncology, offering biomarker tests including OncoDEEP for precision medicine profiling, OncoSELECT for liquid biopsy monitoring, and OncoTRACE for treatment response tracking. The company provides comprehensive molecular profiling services that analyze tumor tissue and blood samples to identify actionable biomarkers, helping oncologists select targeted therapies and immunotherapies for cancer patients. OncoDNA's platform integrates genomic sequencing, bioinformatics analysis, and clinical interpretation to deliver personalized treatment recommendations based on the latest scientific evidence and clinical trial data. The company serves oncologists, cancer centers, and pharmaceutical companies conducting precision oncology research. Founded in 2012 and headquartered in Charleroi, Belgium, OncoDNA has raised approximately $44.5 million in Series C funding from investors including SFPI, SRIW, Sambrinvest, Vesalius Biocapital III, and Ackermans & van Haaren.